CAM
IMGN

Cresset Asset Management’s Immunogen Inc IMGN Stock Holding History

Cresset Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-71,758
Closed -$533K – 1177
2021
Q4 		$533K Buy
71,758
+31,790
+80% +$198K 0.01% 676
2021
Q3 		$226K Buy
39,968
+18,291
+84% +$106K ﹤0.01% 981
2021
Q2 		$143K Buy
21,677
+2,105
+11% +$14.7K ﹤0.01% 976
2021
Q1 		$158K Buy
19,572
+5,665
+41% +$46.3K ﹤0.01% 884
2020
Q4 		$90K Buy
+13,907
New +$81.1K ﹤0.01% 759
2019
Q2 		– Sell
-1,003
Closed -$3K – 1826
2019
Q1 		$3K Buy
1,003
+443
+79% +$1.92K ﹤0.01% 1574
2018
Q4 		$3K Buy
+560
New +$3.4K ﹤0.01% 1235

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cresset Asset Management's IMGN Position: Q1 2022 in Review

Cresset Asset Management sold out of Immunogen Inc (IMGN) in Q1 2022, closing a stake of 71,758 shares — an estimated $533K sold.

Cresset Asset Management first reported a position in IMGN in Q4 2018 and held it in 7 quarters. The position peaked at $533K in Q4 2021. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2022.

  • Cresset Asset Management reported no remaining Immunogen Inc position as of Q1 2022 after selling out during the quarter.
  • Cresset Asset Management sold 71,758 Immunogen Inc shares in Q1 2022, an estimated $533K.
  • Cresset Asset Management first reported a position in Immunogen Inc in Q4 2018 and held it in 7 quarters.
  • Cresset Asset Management's Immunogen Inc position peaked at $533K in Q4 2021.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2022.

Based on Cresset Asset Management's 13F filing for Q1 2022, filed 16 May 2022.